Catalyst Wire Dossier Catalyst Wire Dossier

Alefacept

Alefacept
Drug timelines are a Plus or Pro feature.

17 regulatory and trial events tracked for Alefacept, covering 2007-12-10 to 2017-10-02. Get the full timeline:

Most recent: Clinical Trial Update: Alefacept in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma or Peripheral T-Cell Non-Hodgkin's Lymphoma [Phase 1]

See pricing